MedPath

ORGOVYX

ORGOVYX

Approved
DIN Number

02542137

Drug Class

Human

Market Date

Dec 6, 2023

Company
HC

Sumitomo Pharma Switzerland GmbH

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02542137
AIG Number0165101001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BX04 RELUGOLIX
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:18.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

RELUGOLIXActive
Strength: 120 MG
Monograph: RELUGOLIX

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.